This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

November 4–6, 2024Stockholm, Sweden

Kajikawa Masunori
President and CEO at Rebirthel Co., Ltd.


Masunori Kajikawa is a president and CEO of Rebirthel. He majored in organic synthesis chemistry at the Faculty of Engineering, Yokohama National University, and in medicine at the Research Institute of Environmental Medicine, Faculty of Medicine, Nagoya University. He started his career in a reagent and diagnostic agent manufacturing company. He was engaged in sales, pharmaceutical development, and research & development. In 2005, he co-founded ACTGen, Inc. with Professor Toshio Kitamura, the Institute of Medical Science, University of Tokyo. He served as the executive officer of the R&D dep. and later CEO. In 2013, ACTGen was absorbed and merged by Medical & Biological Laboratories (MBL), therefore he changed his position to a director of the corporate planning department. Afterward, he transferred to MBL International Corporation (USA) and served as the vice president. In 2021, he joined Rebirthel.

Agenda Sessions

  • Japanese bioindustry strategy update